Ginkgo Bioworks Holdings Inc. (DNA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ginkgo Bioworks Holdings Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$13.32
+18.19% today
Market cap
$725M
Overall quality
23/100
Kronos AI 30-day
−20.6%
0 of 8 simulated paths end higher
Ginkgo Bioworks Holdings Inc. (DNA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $725M. It trades at $13.32, up 18.19% today. Its overall quality score is 23 out of 100, ranked against the whole US market. 3 analysts' average target of $8.00 implies −39.9% from today's price. Kronos AI's 30-day forecast is −20.6% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $8.00 |
| Low – high | $5.00 – $11.00 |
| Analysts | 3 |
| Upside to average | −39.9% |
Kronos AI 30-day forecast
| Expected close | $8.95 (−20.6%) |
| Likely range | −27.6% … −13.1% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 13 |
| Solvency | 29 |
| Growth | 27 |
| Overall | 23 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.